Pathology platform achieves CE-IVD certification for primary diagnosis
Indica Labs, a provider of computational pathology software and services, has announced that its HALO AP has received CE marking for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.
The HALO AP platform was developed by Indica Labs to address the specific needs of anatomic pathology laboratories by supporting a wide range of tissue-based workflows, including primary diagnosis, secondary consults, tumour boards, clinical trials, synoptic reporting, quantitative analytics, and artificial intelligence (AI).
Anatomic pathology is undergoing a major sea change as AI and computational tools become increasingly intertwined with routine digital workflows, and cloud-based technologies become the norm rather than the exception. Supporting image formats from all leading whole-slide scanner manufacturers, and with flexible deployment and integration options, HALO AP was built from the ground up to enable these emerging technologies and future-proof anatomic pathology laboratories moving forward.
HALO AP incorporates state-of-the-art workflow management tools allowing users to standardise reporting steps by defining tasks and dependances, including the ability to integrate quantitative analytics and AI tools built using HALO, HALO AI and third-party platforms. Tasks can be fully automated or delivered in a stepwise, guided fashion simplifying training and deployment. Integrated workflows are locked, secured and audited to prevent tampering or misuse.
With APIs to support connections to LIS/LIMS or other third-party systems, as well as flexible on-premise and cloud deployment options, HALO AP can integrate seamlessly within any organisation’s existing IT infrastructure. For laboratories without an existing LIS/LIMS, HALO AP can act as a fully functional, standalone case and image management system.
Other News
Featured Supplier
Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. We have one mission: to do now what patients need next.
Twenty nine medicines developed by Roche are included in the World Health Organisation Model Lists of Essential Medicines, among them...
Upcoming Events
analytica 2022
Messe München, Germany
June 21-24, 2022
The Genomic and Microbiology Revolution: In Technology We Trust?
Royal Air Force Museum, Hendon, London
19 July 2022
Arab Lab Live 2022
Dubai International Convention & Exhibition Centre Dubai World Trade Centre - Trade Centre - Trade Centre 2 - Dubai - United Arab Emirates
24 - 26 October 2022
Lab Innovations 2022
Hall 2 NEC, Birmingham
2 & 3 November 2022
MEDICA 2022
Messe Düsseldorf D-40474 Düsseldorf, Stockumer Kirchstraße 61
14 - 17 November 2022
Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.
Download the FREE Pathology In Practice app from your device's App store
